# Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT

> **NCT00428129** · PHASE2 · TERMINATED · sponsor: **ThromboGenics** · enrollment: 6 (actual)

## Conditions studied

- Deep Vein Thrombosis

## Interventions

- **DRUG:** microplasmin

## Key facts

- **NCT ID:** NCT00428129
- **Lead sponsor:** ThromboGenics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2008-07
- **Final completion:** 2008-10
- **Target enrollment:** 6 (ACTUAL)
- **Why stopped:** Sponsor's decision to not pursue uPLi for vascular conditions including DVT.
- **Last updated:** 2014-04-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00428129

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00428129, "Microplasmin Administered Via the Trellis-8 Infusion System for Treatment of Acute Iliofemoral DVT". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00428129. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*